Clinical Safety

While medication abortion is FDA-approved for use up to eleven weeks of pregnancy, a new legal effort argues that state-level bans are being undermined by mail-order access. This challenge, currently centered in Louisiana, targets the regulatory framework that allows physicians to prescribe

Although lamotrigine is a staple treatment for bipolar disorder and epilepsy, it triggers a dangerous systemic immune response in approximately one out of every thousand patients. Known as Stevens-Johnson Syndrome, this reaction causes severe skin detachment and organ damage. For years, doctors

Novartis and Bristol Myers Squibb have inadvertently set a new precedent for transparency as they navigate the complex safety challenges of applying oncology tools to chronic autoimmune diseases. This strategic pivot reflects a broader industry realization that the risk-benefit calculus for

Traditional views of Information Technology as an ancillary back-office function are being rejected in favor of a clinical care model. The healthcare sector has reached a tipping point where a network failure is now as critical as a power outage in an intensive care unit. Recent breaches at

Documentation such as bank statements or receipts is required for those seeking to recover up to $500 in ordinary expenses related to credit monitoring and identity fees. This requirement stems from the final resolution of a class-action lawsuit against the Fort Wayne Medical Education Program

Recent setbacks in autoimmune trials have prompted a return to more established, well-validated manufacturing standards to ensure long-term patient stability. While the initial migration of Chimeric Antigen Receptor T-cell therapy from liquid tumors to refractory autoimmune diseases sparked immense